deCODE biostructures Announces Fragments of Life™ Milestone and Extension with InterMune
News Jan 29, 2008
deCODE biostructures, Inc has announced that it successfully met a development milestone under its agreement with InterMune via delivery of multiple small molecule fragments to a proprietary protein target.
The structures represent chemotypes and provide new scaffolds for developing unique small molecule drugs. In connection with the achievement of this milestone, deCODE and InterMune agreed to extend their collaborative research agreement.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.